Artificial Intelligence, COVID-19, and the Future of Pandemics
Artificial intelligence (AI) has proven of value in the COVID-19 pandemic and shows promise for mitigating future healthcare crises.
Search
Dec 02, 2024
2024 Judicial Review: Significant Court Decisions on Medical Liability Issues
Between fall 2023 and summer 2024, state supreme courts handed down mixed decisions on medical liability issues affecting healthcare professionals.
From
The Doctor’s Advocate
Shoulder Dystocia Documentation: Implementing a Protocol
Shoulder dystocia claims have traditionally been among the most problematic to defend.
Jun 05, 2025
Advancing and Protecting Medical Liability Reforms
TDC Group’s recent medical liability advocacy work has seen success nationwide, with opportunities to enact new reforms in some states, while still facing difficult environments in others.
From
The Doctor’s Advocate
Social Inflation Causes Between $2.4 and $3.5 Billion of All Medical Malpractice Losses, The Doctors Company Study Finds
In the decade ending in 2021, between $2.4 and $3.5 billion, or 8 to 11 percent, of all medical malpractice losses incurred by physician-focused insurers stemmed from social inflation, according to new research from The Doctors Company, the nation’s largest physician-owned medical malpractice insurer and part of TDC Group.
October 01, 2024, Healthcare Risk Management
Respond Carefully to Notice of Intent
Richard Cahill, JD, Vice President and Associate General Counsel, The Doctors Company, part of TDC Group, shares suggestions for how to properly respond to patients who communicate their intent to sue.
Professional Education
Module 3: Safe Prescribing of Opioids and CNS Depressants (Innovations and Smart Approaches in Safe Prescribing)
Learn several new concepts and innovation tips. Learn about the new CDC Guidelines about pain. This program will show how to treat pain, opioid withdrawal, and/or opioid addiction. It will show how to taper opioids and you will learn how to conduct “motivational interviewing.” You will examine multimodal approaches for chronic pain, including physical, psych-behavioral, procedural, and pharmacological modalities. You will be encouraged to use tools for prescribing and tapering opioids and benzodiazepines. You will be provided with an overview of the use of CURES 2.0. Lastly, the program will examine how to best screen patients for use of CNS depressants and marijuana to mitigate the potential for contraindications with opioids. This module consists of seven audio-filled videos. To successfully complete this course, you need to achieve a passing score of 80 percent in the post-test questions.
Billions for Defense: The Pervasive Nature of Defensive Medicine
Physicians practice defensive medicine all the time—some acknowledge and accept it, while others believe it is untrue and unconscionable. The Doctors Company CEO and Chairman Richard E. Anderson, MD, FACP, examines the pervasive nature of defensive medicine in this article.
Randall Nukk
Randall Nukk is physician niche president for Gallagher Healthcare in Itasca, Illinois. His areas of expertise include medical malpractice insurance and coverage and exposure analysis.
August 22, 2023, KevinMD
For Orthopedic Surgeons, an All-of-the-Above Approach Lowers Liability Risks
Jacqueline Ross, RN, PhD, Coding Director, and Eric E. Cleckler, MSN, RN, Patient Safety Risk Manager II, Department of Patient Safety and Risk Management, The Doctors Company, part of TDC Group, analyze orthopedic medical malpractice insurance claims and translate the findings into patient safety insights to help medical professionals pursue best practices for risk mitigation.
